Last Posted: Aug 13, 2019
- Association of CAG Repeats With Long-term Progression in Huntington Disease
DR Langbehn et al, JAMA Neurology, August 12, 2019 - The Prospective Huntington At-Risk Observational Study (PHAROS): The Emotional Well-Being, Safety and Feasibility of Long-Term Research Participation.
Kayson Elise et al. Journal of Huntington's disease 2019 Jul - The choice not to undergo genetic testing for Huntington disease: Results from the PHAROS study.
Anderson Karen E et al. Clinical genetics 2019 May - Experimental Drug For Huntington's Disease Jams Malfunctioning Gene
R Harris, NPR, May 9, 2019 - Recent advances in the therapeutic development for Huntington disease.
Mestre Tiago A et al. Parkinsonism & related disorders 2019 Feb 125-130 - Targeting Huntingtin Expression in Patients with Huntingtons Disease
SJ Tabrizi et al, NEJM, May 6, 2019 - Targeting Huntingtin Expression in Patients with Huntington's Disease.
Tabrizi Sarah J, et al. The New England journal of medicine 2019 5 0. - Presymptomatic testing of those at 25% risk of autosomal dominant neurodegenerative disease- testing team beware.
Delatycki Martin B et al. European journal of human genetics : EJHG 2019 27(1) 20-21 - CRISPR/Cas9-Mediated Genome Editing for Huntington's Disease.
Vachey Gabriel et al. Methods in molecular biology (Clifton, N.J.) 2018 1780463-481 - Nonhuman Primate Models of Huntington's Disease and Their Application in Translational Research.
Aron Badin Romina et al. Methods in molecular biology (Clifton, N.J.) 2018 1780267-284
No hay comentarios:
Publicar un comentario